Issued Patents 2019
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10501519 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | John Scholler, Avery D. Posey | 2019-12-10 |
| 10421960 | RNA engineered T cells for the treatment of cancer | Yangbing Zhao | 2019-09-24 |
| 10357514 | Treatment of cancer using anti-CD19 Chimeric Antigen Receptor | David L. Porter, Marcela Maus, Mariusz A. Wasik, Saar Gill, Joseph A. Fraietta +11 more | 2019-07-23 |
| 10329355 | Compositions and methods for targeting stromal cells for the treatment of cancer | Ellen Puré, Liang-Chuan Wang, Steven M. Albelda, John Scholler | 2019-06-25 |
| 10308717 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Andreas Loew, Marcela Maus, John Scholler +1 more | 2019-06-04 |
| 10286066 | Artificial antigen presenting cells and uses thereof | James L. Riley, Robert Vonderheide, Nicole Aqui, Megan Davis | 2019-05-14 |
| 10273300 | Methods of making chimeric antigen receptor-expressing cells | Felipe Bedoya, Saba Ghassemi, Bruce L. Levine, Jan J. Melenhorst, Michael C. Milone +2 more | 2019-04-30 |
| 10253086 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Hans Bitter, Jennifer Bordeaux, Barbara Brannetti, Jennifer Brogdon, Naveen Dakappagari +12 more | 2019-04-09 |
| 10221245 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Andreas Loew, Marcela Maus, John Scholler | 2019-03-05 |
| 10174095 | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2019-01-08 |